Prostatis Group’s Invesco S&P MidCap 400 Pure Value ETF RFV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-7,155
Closed -$854K 155
2024
Q1
$854K Sell
7,155
-48,912
-87% -$5.52M 0.32% 70
2023
Q4
$6.53M Buy
+56,067
New +$5.73M 2.73% 6

Other funds holding RFV

Prostatis Group's RFV Position: Q2 2024 in Review

Prostatis Group sold out of Invesco S&P MidCap 400 Pure Value ETF (RFV) in Q2 2024, closing a stake of 7,155 shares — an estimated $854K sold.

Prostatis Group first reported a position in RFV in Q4 2023 and held it in 2 quarters. The position peaked at $6.53M in Q4 2023. 78 funds tracked by Wall St. Rank hold RFV as of Q2 2024.

  • Prostatis Group reported no remaining Invesco S&P MidCap 400 Pure Value ETF position as of Q2 2024 after selling out during the quarter.
  • Prostatis Group sold 7,155 Invesco S&P MidCap 400 Pure Value ETF shares in Q2 2024, an estimated $854K.
  • Prostatis Group first reported a position in Invesco S&P MidCap 400 Pure Value ETF in Q4 2023 and held it in 2 quarters.
  • Prostatis Group's Invesco S&P MidCap 400 Pure Value ETF position peaked at $6.53M in Q4 2023.
  • 78 funds tracked by Wall St. Rank held Invesco S&P MidCap 400 Pure Value ETF as of Q2 2024.

Based on Prostatis Group's 13F filing for Q2 2024, filed 21 Mar 2025.